Key Account Manager - Western Canada & Manitoba

The Key Account Manager (KAM), is a field-based expert that strategically drives the commercial objectives of Alnylam’s ATTR approved products. This position will be responsible for 2 indications in the disease areas of hereditary transthyretin amyloidosis (hATTR), and ATTR-CM.

This maternity cover position (13 months) will have a territory that will cover the provinces of British Columbia and Manitoba and the anticipated start date is May 1st.

The Key Account Manager is expected to develop territory specific strategic account plans in the context of the overall product strategy to optimize care for patients, in close alignment and collaboration with functions of Medical Affairs and Marketing, while ensuring full compliance with all relevant company, industry, legal, regulatory and ethical standards.

Summary of Key Responsibilities

• Presents a positive image of the company and develops awareness about RNAi platform to relevant customer groups
• Develops, owns and drives territory business plan, including customer targeting, in line with country strategy in partnership with the Commercial Lead and Medical Affairs team.
• Achieves post-launch KPIs, including frequency, patient and share targets
• Performs detailed analysis of the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment
• Drives patient diagnosis and referral rates by executing against a territory strategy and account specific plans
• Develops trusted relationships with a portfolio of customers to ensure competitive advantage, after developing a thorough understanding of key customer needs and requirements
• Ensures the correct products and services are delivered to customers in a timely manner by collaborating with internal stakeholders and external centers
• Works with Patient Services Program, reactively, to ensure best in class experience for patient and physician.
• Manages and exe­cutes local learning and education activities to drive diagnosis and treatment rates, in collaboration with the Medical Affairs Team for physicians and other HCPs
• Represents Alnylam at local, national and international events and congresses
• Serves as communication link between key customers and internal teams
• Liaises and collaborates with relevant internal staff (Medical Affairs, Commercial Leads, Market Access and Business Operations Manager), and external agencies as required.
• Timely and accurate reporting and continuous diligent maintenance of the CRM database
• Conducts all activities to highest ethical standards in accordance with country code of practice and local Laws and regulations
• Ensures that Adverse Events and Product Complaints are reported to Medical Information as per the Alnylam Adverse Event Reporting Policy and to ensure our responsibility to Health Canada.
• Significant travel approx. 50%, including domestic and international travel

Qualifications

• Greater than 8 years of sales experience in bio/pharmaceutical sales and Key Account Management experience
• Relevant experience in the specialty markets required (Cardiology/Neurology an asset)
• Ability to gain consistent access and develop strong & professional relationships for product promotion with healthcare providers in Academic and community centers (live  and virtually)
• Strong communication skills to engage and influence professionals at all organizational levels
• Strong business acumen to add value to existing health care structures within an established budget.
• Proven project management and outcomes when working with physicians on healthcare system initiatives.
• Ability to draw on previous experiences and insights to generate and maintain appropriate awareness and timely access to treatment
• Ability to travel within a territory including overnights and weekends, and must hold a valid driver's license and passport which permits travel internationally.
• Excellent organizational skills
• University degree with a strong preference for the Life Sciences.

Alnylam Pharmaceuticals is an EEO employer committed to an exciting, diverse, and enriching work environment. 

#LI-Remote 

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.